Recognition of Chlamydia trachomatis by Toll-like receptor 9 is altered during persistence

被引:0
|
作者
Diallo, Aissata [1 ,2 ]
Overman, Grace [1 ,2 ]
Sah, Prakash [1 ,2 ]
Liechti, George W. [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA
[2] Henry Jackson Fdn Adv Mil Med, Bethesda, MD USA
关键词
Chlamydia; innate immunity; TLR9; pathoadaptation; persistence; OUTER-MEMBRANE PROTEIN; IN-VITRO; PROTECTIVE IMMUNITY; GENE-TRANSFER; CELL BIOLOGY; TLR9; DNA; INFECTION; MURIDARUM; MACROPHAGES;
D O I
10.1128/iai.00063-24
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptor 9 (TLR9) is an innate immune receptor that localizes to endosomes in antigen presenting cells and recognizes single stranded unmethylated CpG sites on bacterial genomic DNA (gDNA). Previous bioinformatic studies have demonstrated that the genome of the human pathogen Chlamydia trachomatis contains TLR9 stimulatory motifs, and correlative studies have implied a link between human TLR9 (hTLR9) genotype variants and susceptibility to infection. Here, we present our evaluation of the stimulatory potential of C. trachomatis gDNA and its recognition by hTLR9- and murine TLR9 (mTLR9)-expressing cells. Utilizing reporter cell lines, we demonstrate that purified gDNA from C. trachomatis can stimulate hTLR9 signaling, albeit at lower levels than gDNA prepared from other Gram-negative bacteria. Interestingly, we found that while C. trachomatis is capable of signaling through hTLR9 and mTLR9 during live infections in HEK293 reporter cell lines, signaling only occurs at later developmental time points. Chlamydia-specific induction of hTLR9 is blocked when protein synthesis is inhibited prior to the RB-to-EB conversion, exacerbated by the inhibition of lipooligosaccharide biosynthesis, and is significantly altered during the induction of aberrance/persistence. Our observations support the hypothesis that chlamydial gDNA is released during the conversion between the pathogen's replicative and infectious forms and during treatment with antibiotics targeting peptidoglycan assembly. Given that C. trachomatis inclusions do not co-localize with TLR9-containing vacuoles in the pro-monocytic cell line U937, our findings also hint that chlamydial gDNA is capable of egress from the inclusion, and traffics to TLR9-containing vacuoles via an as yet unknown pathway.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction
    Suwarti, Suwarti
    Yamazaki, Tomohiko
    Svetlana, Chechetka
    Hanagata, Nobutaka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 430 (04) : 1234 - 1239
  • [22] Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancy
    Ziegler, Susanne Maria
    Feldmann, Cai Niklaas
    Hagen, Sven Hendrik
    Richert, Laura
    Barkhausen, Tanja
    Goletzke, Janina
    Jazbutyte, Virginija
    Martrus, Gloria
    Salzberger, Wilhelm
    Renne, Thomas
    Hecher, Kurt
    Diemert, Anke
    Arck, Petra Clara
    Altfeld, Marcus
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2018, 128 : 30 - 37
  • [23] Altered Toll-Like Receptor Signalling in Children with Down Syndrome
    Huggard, Dean
    Koay, W. J.
    Kelly, Lynne
    McGrane, Fiona
    Ryan, Emer
    Lagan, Niamh
    Roche, Edna
    Balfe, Joanne
    Leahy, T. Ronan
    Franklin, Orla
    Moreno-Oliveira, Ana
    Melo, Ashanty M.
    Doherty, Derek G.
    Molloy, Eleanor J.
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [24] Toll-like receptor 2 suppresses Toll-like receptor 9 responses in Peyer's patch dendritic cells
    Kotaki, Ryutaro
    Wajima, Shun-ichi
    Shiokawa, Aya
    Hachimura, Satoshi
    IMMUNOBIOLOGY, 2015, 220 (06) : 734 - 743
  • [25] Nicotine Treatment Improves Toll-Like Receptor 2 and Toll-Like Receptor 9 Responsiveness in Active Pulmonary Sarcoidosis
    Julian, Mark W.
    Shao, Guohong
    Schlesinger, Larry S.
    Huang, Qin
    Cosmar, David G.
    Bhatt, Nitin Y.
    Culver, Daniel A.
    Baughman, Robert P.
    Wood, Karen L.
    Crouser, Elliott D.
    CHEST, 2013, 143 (02) : 461 - 470
  • [26] Expression of Toll-Like Receptor 9 in Horse Lungs
    Schneberger, David
    Caldwell, Sarah
    Suri, Sarabjeet Singh
    Singh, Baljit
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2009, 292 (07): : 1068 - 1077
  • [27] Cathepsins are required for toll-like receptor 9 responses
    Matsumoto, Fumi
    Saitoh, Shin-ichiroh
    Fukui, Ryutaroh
    Kobayashi, Toshihiko
    Tammura, Natsuko
    Konnio, Kazunori
    Kusumoto, Yutaka
    Akashi-Takamura, Sachiko
    Miyake, Kensuke
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 367 (03) : 693 - 699
  • [28] Toll-Like Receptor 9 Agonists for Cancer Therapy
    Melisi, Davide
    Frizziero, Melissa
    Tamburrino, Anna
    Zanotto, Marco
    Carbone, Carmine
    Piro, Geny
    Tortora, Giampaolo
    BIOMEDICINES, 2014, 2 (03) : 211 - 228
  • [29] Therapeutic potential of Toll-like receptor 9 activation
    Arthur M. Krieg
    Nature Reviews Drug Discovery, 2006, 5 : 471 - 484
  • [30] Toll-like Receptor 9: AEP Takes Control
    van Endert, Peter
    IMMUNITY, 2009, 31 (05) : 696 - 698